1. Yang, C.C., Yang, H., Jiang, L.: Postmarketing drug safety surveillance using publicly available health-consumer-contributed content in social media. ACM Trans. Manag. Inf. Syst. (TMIS) 5(1), 2 (2014)
2. Leaman, R., Wojtulewicz, L., Sullivan, R., Skariah, A., Yang, J., Gonzalez G.: Towards internet-age pharmacovigilance: extracting adverse drug reactions from user posts to health-related social networks. In: Proceedings of the Workshop on Biomedical Natural Language Processing, Uppsala, pp. 117–125 (2010)
3. Vilar, S., Harpaz, R., Chase, H.S., Costanzi, S., Rabadan, R., Friedman, C.: Facilitating adverse drug event detecting in pharmacovigilance databases using molecular structure similarity: application to rhadomyolysis. J. Am. Med. Inform. Assoc. 18(suppl. 1), i73–i80 (2011)
4. Zorych, I., Madigan, D., Ryan, P., Bate, A.: Disproportionality methods for pharmacovigilance in longitude observational database. Stat. Methods Med. Res. 22(1), 39–56 (2011)
5. Caster, O., Noren, G.N., Madigan, D., Bate, A.: Large-scale regression-based pattern discovery: the example of screening the WHO global drug safety database. Stat. Anal. Data Min. 3, 197–208 (2010)